A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study

Tanguy Y. Seiwert, Sara Kochanny, Kevin Wood, Francis P. Worden, Douglas Adkins, James L. Wade, Bethany G. Sleckman, Daniel Anderson, Ryan J. Brisson, Theodore Karrison, Walter M. Stadler, Everett E. Vokes

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study'. Together they form a unique fingerprint.

Medicine & Life Sciences